Scynexis logo

Scynexis share price today

(SCYX)

Scynexis share price is $1.32 & ₹113.27 as on 7 Jan 2025, 2.30 'hrs' IST

$1.32

▲

-0.09

(-6.38%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Scynexis share price in Dollar and Rupees. Guide to invest in Scynexis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Scynexis, along with analyst recommendations, forecasts, and comprehensive financials.

Scynexis share price movements

  • Today's Low: $1.32
    Today's High: $1.40

    Day's Volatility :5.71%

  • 52 Weeks Low: $0.90
    52 Weeks High: $3.07

    52 Weeks Volatility :70.66%

Scynexis Returns

PeriodScynexis IncIndex (Russel 2000)
3 Months
-5.37%
0.0%
6 Months
-28.06%
0.0%
1 Year
-30.2%
0.0%
3 Years
-76.38%
-19.8%

Scynexis Key Statistics

in dollars & INR

Previous Close
$1.41
Open
$1.41
Today's High
$1.4
Today's Low
$1.32
Market Capitalization
$45.9M
Today's Volume
$552.2K
52 Week High
$3.07
52 Week Low
$0.9006
Revenue TTM
$8.6M
EBITDA
$-52.4M
Earnings Per Share (EPS)
$-0.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.42%

How to invest in Scynexis from India?

It is very easy for Indian residents to invest directly in Scynexis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Scynexis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Scynexis or SCYX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Scynexis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Scynexis shares which would translate to 0.650 fractional shares of Scynexis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Scynexis, in just a few clicks!

Returns in Scynexis for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Scynexis investment value today

Current value as on today

₹68,569

Returns

₹31,431

(-31.43%)

Returns from Scynexis Stock

₹34,653 (-34.65%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Scynexis

70%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Scynexis on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 70% more investors are searching Scynexis in the last 30 days versus the previous period.

Global Institutional Holdings in Scynexis

  • Federated Hermes Inc

    9.47%

  • Kingdon Capital Management LLC

    5.90%

  • Vanguard Group Inc

    4.45%

  • Avidity Partners Management LP

    3.82%

  • AMH Equity Ltd

    1.58%

  • Davidson D A & Co

    1.39%

Analyst Recommendation on Scynexis

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Scynexis(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Scynexis

What analysts predicted

Upside of 405.05%

Current:

$1.32

Target:

$6.67

Insights on Scynexis

  • Price Movement

    In the last 7 days, SCYX stock has moved up by 31.8%

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 5.79M → 660.0K (in $), with an average decrease of 44.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -14.45M → -2.80M (in $), with an average increase of 414.9% per quarter

  • SCYX vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 12.0% return, outperforming this stock by 37.4%

  • Price to Sales

    ForSCYX every $1 of sales, investors are willing to pay $8.0, whereas for Haleon Plc Spon Ads, the investors are paying $3.9 for every $1 of sales.

Scynexis Financials in INR & Dollars

FY18Y/Y Change
Revenue
$257.0K
↑ 0.0%
Net Income
$-12.5M
↓ 50.25%
Net Profit Margin
-4.9K%
↑ 4899.61%
FY19Y/Y Change
Revenue
$121.0K
↓ 52.92%
Net Income
$-55.2M
↑ 343.01%
Net Profit Margin
-45.6K%
↓ 40796.57%
FY20Y/Y Change
Revenue
$12.1M
↑ 9858.68%
Net Income
$-55.2M
↓ 0.09%
Net Profit Margin
-457.97%
↑ 45189.96%
FY21Y/Y Change
Revenue
$13.2M
↑ 9.24%
Net Income
$-32.9M
↓ 40.44%
Net Profit Margin
-249.68%
↑ 208.29%
FY22Y/Y Change
Revenue
$5.1M
↓ 61.32%
Net Income
$-62.8M
↑ 91.11%
Net Profit Margin
-1.2K%
↓ 984.05%
FY23Y/Y Change
Revenue
$140.1M
↑ 2652.72%
Net Income
$67.0M
↓ 206.74%
Net Profit Margin
47.84%
↑ 1281.57%
Q2 FY23Q/Q Change
Revenue
$131.5M
↑ 11533.1%
Net Income
$122.3M
↓ 319.8%
Net Profit Margin
93.01%
↑ 5015.4%
Q3 FY23Q/Q Change
Revenue
$1.8M
↓ 98.66%
Net Income
$-1.8M
↓ 101.44%
Net Profit Margin
-99.77%
↓ 192.78%
Q4 FY23Q/Q Change
Revenue
$5.8M
↑ 229.19%
Net Income
$-19.6M
↑ 1014.74%
Net Profit Margin
-337.86%
↓ 238.09%
Q1 FY24Q/Q Change
Revenue
$1.4M
↓ 76.32%
Net Income
$411.0K
↓ 102.1%
Net Profit Margin
29.93%
↑ 367.79%
Q2 FY24Q/Q Change
Revenue
$736.0K
↓ 46.39%
Net Income
$-14.5M
↓ 3617.76%
Net Profit Margin
-2.0K%
↓ 1994.33%
Q3 FY24Q/Q Change
Revenue
$660.0K
↓ 10.33%
Net Income
$-2.8M
↓ 80.58%
Net Profit Margin
-425.45%
↑ 1538.95%
FY18Y/Y Change
Profit
$257.0K
↑ 0.0%
FY19Y/Y Change
Profit
$121.0K
↓ 52.92%
FY20Y/Y Change
Profit
$-303.0K
↓ 350.41%
FY21Y/Y Change
Profit
$12.9M
↓ 4341.25%
FY22Y/Y Change
Profit
$4.5M
↓ 65.27%
FY23Y/Y Change
Profit
$124.5M
↑ 2689.98%
Q2 FY23Q/Q Change
Profit
$131.0M
↑ 13095.17%
Q3 FY23Q/Q Change
Profit
$1.4M
↓ 98.95%
Q4 FY23Q/Q Change
Profit
$-9.0M
↓ 752.39%
Q1 FY24Q/Q Change
Profit
$1.4M
↓ 115.23%
Q2 FY24Q/Q Change
Profit
$736.0K
↓ 46.39%
Q3 FY24Q/Q Change
Profit
$660.0K
↓ 10.33%
FY18Y/Y Change
Operating Cash Flow
$-28.3M
↑ 15.34%
Investing Cash Flow
$-803.0K
↓ 91.65%
Financing Cash Flow
$29.4M
↑ 194.56%
FY19Y/Y Change
Operating Cash Flow
$-38.1M
↑ 34.59%
Investing Cash Flow
$26.2M
↓ 3367.75%
Financing Cash Flow
$42.3M
↑ 43.78%
FY20Y/Y Change
Operating Cash Flow
$-49.4M
↑ 29.47%
Investing Cash Flow
$6.5M
↓ 75.33%
Financing Cash Flow
$94.0M
↑ 122.2%
FY21Y/Y Change
Operating Cash Flow
$-54.6M
↑ 10.55%
Investing Cash Flow
$-1.2M
↓ 118.1%
Financing Cash Flow
$67.1M
↓ 28.6%
Q2 FY23Q/Q Change
Operating Cash Flow
$74.4M
↓ 493.16%
Investing Cash Flow
$-6.4M
↑ 0.0%
Financing Cash Flow
$-36.6M
↓ 166654.55%

Scynexis Technicals Summary

Sell

Neutral

Buy

Scynexis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Scynexis Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Scynexis Inc
Scynexis Inc
14.63%
-28.06%
-30.2%
-76.38%
-85.97%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
6.95%
-3.63%
3.11%
80.66%
21.4%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
-1.87%
9.87%
9.24%
27.67%
27.67%
Zoetis Inc.
Zoetis Inc.
-8.33%
-6.27%
-16.74%
-23.18%
20.92%
Viatris Inc.
Viatris Inc.
-4.06%
13.7%
4.87%
-18.19%
-24.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Scynexis Inc
Scynexis Inc
0.88
NA
0.0
-0.46
-0.48
-0.27
NA
1.54
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
36.83
36.83
0.33
6.37
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
28.91
28.91
1.72
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
30.57
30.57
2.53
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
Viatris Inc.
224.4
NA
0.08
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Scynexis Inc
Scynexis Inc
Buy
$45.9M
-85.97%
0.88
0.0%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.0B
21.4%
36.83
17.21%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$43.1B
27.67%
28.91
10.75%
Zoetis Inc.
Zoetis Inc.
Buy
$73.5B
20.92%
30.57
26.55%
Viatris Inc.
Viatris Inc.
Hold
$14.9B
-24.85%
224.4
-5.87%

About Scynexis

scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. we are developing our lead product candidate, scy-078, a novel antifungal in phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.
Organization
Scynexis
Employees
29
CEO
Dr. David Gonzalez Angulo M.D.
Industry
Health Technology

Management People of Scynexis

NameTitle
Dr. David Gonzalez Angulo M.D.
CEO, President & Director
Mr. Ivor Macleod CPA, M.B.A.
Chief Financial Officer
Mr. Scott Sukenick J.D.
Chief Legal Officer & Corporate Secretary
Ms. Daniella Gigante
Vice President of Human Resources & Information Technology

Important FAQs about investing in Scynexis from India :

What is Scynexis share price today?

Scynexis share price today stands at $1.32, Open: $1.41 ; Previous Close: $1.41 ; High: $1.40 ; Low: $1.32 ; 52 Week High: $3.07 ; 52 Week Low: $0.90. The stock opens at $1.41, after a previous close of $1.41. The stock reached a daily high of $1.40 and a low of $1.32, with a 52-week high of $3.07 and a 52-week low of $0.90.

Can Indians buy Scynexis shares?

Yes, Indians can invest in the Scynexis (SCYX) from India.

With INDmoney, you can buy Scynexis at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Scynexis at zero transaction cost.

How can I buy Scynexis shares from India?

It is very easy to buy Scynexis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Scynexis be purchased?

Yes, you can buy fractional shares of Scynexis with INDmoney app.

What are the documents required to start investing in Scynexis stocks?

To start investing in Scynexis, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Scynexis

Today’s highest price of Scynexis (SCYX) is $1.40.

Today’s lowest price of Scynexis (SCYX) is $1.32.

What is today's market capitalisation of Scynexis

Today's market capitalisation of Scynexis SCYX is 45.9M

What is the 52 Week High and Low Range of Scynexis

  • 52 Week High

    $3.07

  • 52 Week Low

    $0.90

What are the historical returns of Scynexis?

  • 1 Month Returns

    14.63%

  • 3 Months Returns

    -28.06%

  • 1 Year Returns

    -30.2%

  • 5 Years Returns

    -85.97%

Who is the Chief Executive Officer (CEO) of Scynexis

Dr. David Gonzalez Angulo M.D. is the current Chief Executive Officer (CEO) of Scynexis.